Skip to content
Her Choice

Supreme Court Leaves Mifepristone Access Unchanged- For Now

n addition to ongoing litigation, last September the Trump administration FDA, after requests from anti-abortion organizations and state attorneys general, initiated an internal review of mifepristone’s safety.

Supreme Court Leaves Mifepristone Access Unchanged- For Now

Need Support?

Find verified resources for reproductive healthcare, support services, and advocacy organizations.

Find Resources